Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Mar 27, 2024; 16(3): 823-832
Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.823
Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.823
Number of patients | n = 28 |
Sex | |
Male | 16 (57.1) |
Female | 12 (42.9) |
Age, yr | 58.5 ± 16.3 |
BMI, kg/m2 | 26.2 ± 4.1 |
Patient type | |
Stoma-site reinforcement | 21 (75.0) |
Incisional | 4 (14.3) |
Stoma-site/incisional | 3 (10.7) |
CDC wound class | |
Class I: Clean | 3 (10.7) |
Class II: Clean/contaminated | 2 (7.1) |
Class III: Contaminated | 23 (82.1) |
Recurrent | 5 (17.9) |
Prior hernia repairs | 5 (17.9) |
Prior wound infection | 6 (21.4) |
Transplant patient | 0 (0) |
Stoma present | 22 (78.6) |
Cancer | 17 (60.7) |
Immunosuppression/steroid use | 19 (67.9) |
Hypoalbuminemia (albumin < 3.7 g/dL) | 12 (42.9) |
Diabetes | 10 (35.7) |
COPD/chronic cough | 8 (28.6) |
Smoking | 8 (28.6) |
MRSA | 0 (0) |
Value | |
Surgical approach | |
Open | 3 (10.7) |
Laparoscopic | 15 (53.6) |
Robotic | 10 (35.7) |
Implant location | |
Sublay | 23 (82.1) |
IPOM | 5 (17.9) |
Matrix | |
OviTex 1S® | 5 (17.9) |
OviTex LPR® | 23 (82.1) |
Duration of surgery | 85.7 min ± 40.9 min |
Defect dimensions | |
Length | 7.5 cm ± 3.9 cm |
Width | 6.9 cm ± 3.4 cm |
Mesh dimensions (cm × cm) | |
9 × 9 | 20 (71.4) |
10 × 12 | 2 (7.1) |
16 × 20 | 4 (14.3) |
20 × 20 | 2 (7.1) |
Component separation | |
Left myocutaneous flap | 2 (7.1) |
Right myocutaneous flap | 18 (64.3) |
Bilateral | 2 (7.1) |
Unspecified | 1 (3.6) |
None | 5 (17.9) |
Bowel anastomosis | 23 (82.1) |
Intraoperative blood transfusion | 0 (0) |
Concomitant procedure(s) | 0 (0) |
Drains placed | |
At least one | 24 (85.7) |
None | 4 (14.3) |
Drain locations | |
Abdominal wall | 0 (0) |
Subcutaneous | 23 (82.1) |
Retromuscular | 3 (10.7) |
Skin closure | 3 (10.7) |
Vacuum-assisted closure device | 0 (0) |
Item | 1 month | 1 yr |
Number of patients | 28 | 28 |
Primary endpoint | ||
Hernia recurrence | 0 (0) | 0 (0) |
Secondary endpoints | ||
Length of stay | 2.1 d ± 1.2 d | NA |
Return to work | 8.3 d ± 3.0 d | NA |
Readmission | 3 (10.7) | 0 (0) |
Wound | 0 (0) | 0 (0) |
Mesh infection | 2 (7.1) | 0 (0) |
Gastrointestinal | 2 (7.1) | 0 (0) |
Surgical site infection | ||
Superficial | 0 (0) | NA |
Deep | 0 (0) | NA |
Seroma | 0 (0) | 0 (0) |
Hematoma | 0 (0) | NA |
Wound dehiscence | 0 (0) | NA |
Fistula | 2 (7.1) | 0 (0) |
Mechanical obstruction | 0 (0) | 0 (0) |
Mesh infection | 2 (7.1) | 0 (0) |
Mesh removal | 1 (3.6) | 0 (0) |
- Citation: Lake SP, Deeken CR, Agarwal AK. Reinforced tissue matrix to strengthen the abdominal wall following reversal of temporary ostomies or to treat incisional hernias. World J Gastrointest Surg 2024; 16(3): 823-832
- URL: https://www.wjgnet.com/1948-9366/full/v16/i3/823.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i3.823